Searched for
ARAGEN FUNDING
From OYO's Ritesh Agarwal to BlissClub's Minu Margaret: Check out 155 entrepreneurs in Hurun India's under-35 listAvendus Wealth and Hurun India have unveiled the U35 List, celebrating 155 exceptional young leaders under 35. These entrepreneurs are driv...- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Avendus Fund, SBI Life lead funding in AragenAvendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...
- Quadria's third fund nets $1 billion, to deploy 60% in IndiaQuadria Capital, an Asia healthcare-focused private equity firm, has successfully raised $1.07 billion for its third fund, surpassing its i...
- Quadria Capital invests $100 million in Aragen LifeIn this pre-IPO round, Quadria will acquire the minority stake in Aragen, at an approximate valuation of $1.4 bn, primarily through a fresh...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Western Carriers IPO subscribed nearly 14 times as on day 4, GMP down to 29%. Check detailsWestern Carriers' IPO has been subscribed 13.88 times, driven by strong demand from retail and non-institutional investors. The company pla...
- Arkade Developers IPO subscribed by nearly 30 times as on Day 3. Check GMP, other detailsArkade Developers' IPO has been oversubscribed 30.2 times. Analysts recommend subscribing due to the company's strategic positioning in Mum...
- Bajaj Housing Finance shares under pressure after multibagger rally. Should you buy or sell?Bajaj Finance shares rallied post-IPO but faced pressure today, declining 2%. Analysts recommend waiting for a price correction before buyi...
- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- ChrysCapital eyes stake in Delhi's Centre For Sight eye hospitalChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...
- Goldman Sachs buys stake in contract research firm Aragen Life SciencesAragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...
- Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
- Global PE funds eye stake in GVK Bio, co valued at $800 mnIn this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...
- GVK Biosciences plans Rs 100 crore active pharmaceutical ingredients facilityGVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...
Load More
